Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 1993.
Business Overview: Humana operates managed care health plans, primarily Health Maintenance Organizations (HMOs) and Preferred Provider Organizations (PPOs), serving Commercial groups and Medicare-eligible individuals. On March 1, 1993, the Company completed a "Spinoff," separating its acute-care hospital business into a new entity, Galen Health Care, Inc. (later merged with Columbia/HCA). Consequently, Humana changed its fiscal year-end from August 31 to December 31 and now focuses exclusively on the managed care health plan business.
Key Financial Metrics
Revenue: Total premium revenues for the year ended December 31, 1993, were approximately $3.1 billion.
- Commercial HMO: $1.4 billion (43% of total premiums).
- Medicare Risk (HCFA Contracts): Approximately $1.2 billion (40% of total premiums). Notably, one contract in Florida accounted for $1 billion (80% of HCFA revenues).
- Commercial PPO: $357 million (11% of total premiums).
- Medicare Supplement: $132 million.
- Other Services: Administrative services ($5 million), prescription drug management ($3 million), and dental services ($2 million).
Profitability and Cash Flow: The provided text does not contain the consolidated income statement or cash flow statement figures for the full year. However, the Parent Company Condensed Statement of Operations reports a Net Income of $89 million for the year ended December 31, 1993, driven largely by equity in income of subsidiaries ($118 million) offset by a loss before equity of $(29 million). The Parent Company Condensed Statement of Cash Flows shows net cash provided by operating activities of $20 million.
Debt and Liquidity:
- Parent Company Cash: $27 million as of December 31, 1993.
- Parent Company Total Assets: $1,077 million.
- Parent Company Total Liabilities: $188 million.
- Credit Facility: A $200 million Credit Agreement was entered into on January 12, 1994.
Membership (as of Dec 31, 1993): Total membership was 1,638,400.
- Commercial HMO: 986,000
- Commercial PPO: 228,000
- Medicare Risk: 270,800
- Medicare Supplement: 153,600
Material Changes vs. Prior Period
- Corporate Structure: The most significant change was the March 1, 1993, Spinoff of the hospital business (Galen), transforming Humana from a diversified health care provider into a pure-play managed care organization.
- Fiscal Year: The fiscal year-end was shifted from August 31 to December 31 to align with the new business focus.
- Revenue Concentration: The Florida Medicare Risk contract became a dominant revenue source, representing 32% of total premium revenues ($1 billion of $3.1 billion).
- Acquisitions: The Company acquired an HMO in Washington, D.C. (125,000 members) for $55 million on February 28, 1994 (post-period).
Outlook, Risks, and Contingencies
Management Commentary and Outlook:
- Rate Increases: Effective January 1, 1994, payments under HCFA contracts increased by an average of 3%.
- Health Care Reform: Management believes the Company is well-positioned for national health care reform, which is anticipated to be implemented after 1994. Florida state reform legislation was adopted in 1993, requiring registration as an Accountable Health Partnership (AHP) to sell to certain groups.
Risks and Contingencies:
- Concentration Risk: Termination of the Florida HCFA contract would have a "material adverse effect" on revenues and profitability. Changes in Medicare risk program payments or mandated benefit increases without corresponding payment hikes also pose significant risks.
- Regulatory Risk: The Company is subject to extensive federal (HCFA) and state regulations regarding HMO qualification, financial stability, and quality assurance. HCFA audits are conducted at least biannually.
- Legal Proceedings:
- Forsyth Case: A class action lawsuit regarding benefit calculations resulted in a summary judgment for plaintiffs on a third amended complaint in January 1994. The Company believes the final resolution will not have a material adverse effect.
- Lewis v. Austen: A shareholder derivative action regarding stock option plan amendments during the Spinoff is pending; the Company believes the complaint is without merit.
- Cost Control: Future ability to control costs may be adversely affected by new technologies, inflation, and increasing hospital costs.
Investor Verification Checklist
- Florida Contract Dependency: Verify the stability and renewal terms of the Florida HCFA contract, which accounts for 32% of total revenue.
- Post-Spinoff Performance: Review the full consolidated financial statements (incorporated by reference) to assess profitability margins and cash flow generation independent of the hospital business.
- Regulatory Compliance: Monitor HCFA audit results and the impact of Florida's new Community Health Purchasing Alliance (CHPA) legislation on market access.
- Legal Exposure: Track the damages assessment in the Forsyth case and the status of the Lewis v. Austen derivative suit.
- Acquisition Integration: Assess the financial impact and integration progress of the Washington, D.C. HMO acquisition closed in February 1994.